This message is sent to you by FDA Newswatch

GMPs for Medical Marijuana Production Operations Cannabis GMP

Friday, 02 August 2019 10:00 AM PDT, 01:00 PM EDT

Training Duration = 60 min                  Sponsored by Online Compliance Panel

Click Here to register $229.00

Click Here to register and receive CD recording $329.00

Legal marijuana is one of the fastest-growing industries in the U.S., with more and more states starting to legalize medical marijuana to varying levels of control and regulation.

However, the federal government has not yet legalized medical cannabis (though this situation might soon change). As a result, the industry lacks a common framework/standard for food safety - compared to other industries like pharmaceuticals and food.

In such a scenario, companies that produce and sell marijuana products have a huge challenge ahead of them: how do they ensure that their products are safe - and how do they maintain their consumers' trust. Leaders in the cannabis industry are leading the way out of this confusion and opting for high safety and Good Manufacturing Practices (GMPs) - and so should you.

Objectives of the Presentation:

  • Cannabis GMP overview
  • Regulatory history
  • Forms of medical marijuana
  • General requirements - acquisition of cannabis
  • Operational plans and procedures
  • Personnel
  • Documentation and training
  • Facilities - grower/processor
  • Plants versus Seeds
  • Visitor access
  • Security and surveillance
  • Growing and processing requirements
  • Inventory
  • Storage
  • Equipment operation & maintenance
  • Sanitation and safety
  • Packaging and labeling
  • Transportation and tracking
  • Disposal of medical marijuana waste
  • Complaints and recall handling
  • Pesticides and pest handling

Why Should You Attend:

Good Manufacturing Practice (GMP) regulations established by the U.S. Food and Drug Administration have the force of law. GMPs require that manufacturers, processors, and packagers of drugs, medical devices, and some food and blood products take proactive steps to ensure that their products are safe, pure, and effective.

Since medical marijuana is not a legally recognized and regulated medicinal product in the U.S., you can only review GMPs as they relate to the wide range of international and U.S. individual state cannabis regulations, along with existing non-cannabis GMPs, to determine how to best run your cannabis operations. However, it's almost certain that cannabis regulations will require GMP certification in the future. Plus, consumers prefer to buy cannabis-infused products with the certification.

Therefore, it is critical that as cannabis production takes its place in the mainstream of U.S. medicinal production, all companies currently operating under individual state auspices understand and align their operations with existing GMPs so that they are in compliance when cannabis is federally recognized.

In this webinar we will discuss the basics of GMP for any medical marijuana production operation, so that your unit is fully compliant when cannabis is federally recognized. Get up to speed with the different forms of medical marijuana, the general requirements for acquiring cannabis, as well as the packaging, labeling, transportation and tracking requirements for medical marijuana - plus disposal of medical marijuana waste.

We will also discuss operational plans and procedures, and documentation and training. Will teach you about the grower/processor facilities; explain the difference between plants and seeds, and the nuts and bolts of security, surveillance and visitor access. You will learn about growing and processing requirements, inventory, storage, and pest handling. Plus, you'll learn how to handle complaints and recalls.

Instructor Profile:

Charles H. Paul is the President of C. H. Paul Consulting, Inc. - a regulatory, Lean Manufacturing, training, and technical documentation consulting firm. Charles is a management consultant, instructional designer and regulatory consultant and has led C. H. Paul Consulting, Inc. since its inception over 25 years ago.

He regularly consults with Fortune 500 pharmaceutical, medical device, and biotechnology firms assisting them in achieving human resource, regulatory, and operational excellence.

He is a regular presenter of webinars and on-site seminars in a variety of related subjects from documentation development to establishing compliant preventive maintenance systems. The firm works globally completing projects throughout the EU, UK, South America, and Asia.